Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: A cross-sectional study from the Third National Health and Nutrition Examination Survey

Journal of Investigative Medicine

Volumn 65, Issue 1, 2017, Pages 43-48

  Shen, Huafeng ^a   Peng, Jennifer L ^b   Tayarachakul, Sucharat ^b   Liangpunsakul, Suthat ^b,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b INDIANA UNIVERSITY   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HEPATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; POPULATION RESEARCH; PREVALENCE; SELF REPORT; SMOKING; UNITED STATES; YOUNG ADULT; BLOOD; DEMOGRAPHY; NUTRITION;

ADULT; COTININE; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; HUMANS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION SURVEYS; PREVALENCE; SMOKING;

EID: 85035316566     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.1136/jim-2016-000213     Document Type: Article

References (29)

1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55:2005-23.
2. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917-23.
3. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50:1844-50.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
5. Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS ONE 2012; 7:e47791.
6. Clair C, Chiolero A, Faeh D, et al. Dose-dependent positive association between cigarette smoking, abdominal obesity and body fat: cross-sectional data from a population-based survey. BMC Public Health 2011; 11:23.
7. Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, et al. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med 2013; 11:195.
8. Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, et al. Smoking is not associated with nonalcoholic fatty liver disease. World J Gastroenterol 2006; 12:5196-200.
9. Liu Y, Dai M, Bi Y, et al. Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. J Epidemiol 2013; 23:115-21.
10. Bodmer CW, MacFarlane IA, Flavell HJ, et al. How accurate is the smoking history in newly diagnosed diabetic patients? Diabetes Res Clin Pract 1990; 10:215-20.
11. Masson EA, MacFarlane IA, Priestley CJ, et al. Failure to prevent nicotine addition in young people with diabetes. Arch Dis Child 1992; 67:100-2.
12. Belin RM, Astor BC, Powe NR, et al. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004; 89:6077-86.
13. NHANES Ultrasound procedure manual. http://www.cdc.gov/nchs/data/nhanes/nhanes3/hepatic-steatosis-ultrasound-procedures-manual.pdf (accessed 7 Jul 2016).
14. Analytic and Reporting Guidelines: The National Health and Nutrition Examination Survey (NHANES). http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/nhanes-analytic-guidelines-dec-2005.pdf (accessed 7 Jul 2016).
15. Centers for Disease Control and Prevention (CDC). Cigarette smoking-attributable morbidity - United States, 2000. MMWR Morb Mortal Wkly Rep 2003; 52:842-4.
16. Lazo M, Hernaez R, Eberhardt MS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2013; 178:38-45.
17. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163:427-36.
18. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-19.
19. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010; 59:1410-15.
20. Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298:2654-64.
21. Jatoi NA, Jerrard-Dunne P, Feely J, et al. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 2007; 49:981-5.
22. Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300:2765-78.
23. Pessione F, Ramond MJ, Njapoum C, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001; 34:121-5.
24. Bennett H, McEwan P, Sugrue D, et al. Assessing the long-term impact of treating hepatitis C virus (HCV)-infected people who inject drugs in the UK and the relationship between treatment uptake and efficacy on future infections. PLoS ONE 2015; 10:e0125846.
25. Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 2015; 41:65-76.
26. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese Male office workers. Ind Health 2005; 43:295-301.
27. Chiolero A, Faeh D, Paccaud F, et al. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008; 87:801-9.
28. Chen CC, Li TC, Chang PC, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metab Clin Exp 2008; 57:544-8.
29. Rabaeus M, Salen P, de Lorgeril M. Is it smoking or related lifestyle variables that increase metabolic syndrome risk? BMC Med 2013; 11:196.